AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Truegliclaz M 60mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Truecure Healthcare Private Limited

Salt Composition

Gliclazide (60mg) + Metformin (500mg)

Overview Truegliclaz M 60mg/500mg Tablet ER

Glimepiride/Metformin extended-release tablets (60mg/500mg) are classified as antidiabetic agents. This dual-action medication manages type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is only one component of a comprehensive diabetes management plan, which necessitates a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common adverse effects include hypoglycemia (low blood sugar), characterized by symptoms like sweating, dizziness, headache, and tremors; constipation; and vomiting. Regular meals and readily available glucose sources (e.g., sugary foods or juice) are essential to mitigate hypoglycemia. Alcohol consumption should be avoided due to its potential to exacerbate hypoglycemia. Additional possible side effects encompass altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before initiating treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Uses of Truegliclaz M 60mg/500mg Tablet ER

Adult-onset diabetes

Major Benefits of Truegliclaz M 60mg/500mg Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. The Truegliclaz M 60mg/500mg Extended-Release tablet should be administered with a meal.

Common Side effects of Truegliclaz M 60mg/500mg Tablet ER:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Truegliclaz M 60mg/500mg Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the entire tablet; do not chew, crush, or fracture it. Administer Truegliclaz M 60mg/500mg Extended-Release Tablet with a meal.

How Truegliclaz M 60mg/500mg Tablet ER works:

Extended-release Truegliclaz M tablets (60mg gliclazide/500mg metformin) combine the antidiabetic actions of gliclazide and metformin.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Truegliclaz M 60mg/500mg Extended-Release Tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Truegliclaz M 60mg/500mg tablets pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Truegliclaz M 60mg/500mg tablets are likely unsuitable for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Truegliclaz M 60mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. This medication is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Truegliclaz M 60mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consult a physician. A reduced initial dose is usually recommended for individuals with mild to moderate liver disease; the medication is unsuitable for those with severe hepatic dysfunction.

What if you forget to take Truegliclaz M 60mg/500mg Tablet ER :

Should you forget to take a Truegliclaz M 60mg/500mg Extended-Release tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Truegliclaz M 60mg/500mg Tablet ER

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Truegliclaz M 60mg/500mg Tablet ER

Truegliclaz M 60mg/500mg Extended-Release tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood glucose control when used with a healthy diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Truegliclaz M 60mg/500mg ER tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Truegliclaz M 60mg/500mg ER tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with skipped meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Truegliclaz M 60mg/500mg Tablet ER can cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency characterized by excessive blood lactic acid. This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Truegliclaz M 60mg/500mg Tablet ER and seek immediate medical attention.
Prolonged use of Truegliclaz M 60mg/500mg ER tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually, according to some studies.
Patients with known allergies to Truegliclaz M 60mg/500mg Tablet ER components or excipients, or those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis), should not use this medication.
Consuming alcohol with Truegliclaz M 60mg/500mg ER tablets is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Truegliclaz M 60mg/500mg ER tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Truegliclaz M 60mg/500mg ER tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Truegliclaz M 60mg/500mg ER tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or use with other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Truegliclaz M 60mg/500mg Tablet ER can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excess blood lactic acid. This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Truegliclaz M 60mg/500mg Tablet ER and seek immediate medical attention.
Prolonged use of Truegliclaz M 60mg/500mg Tablet ER can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Patients with known allergies to Truegliclaz M 60mg/500mg Tablet ER components or excipients, or those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis), should not use this medication.
Combining alcohol with Truegliclaz M 60mg/500mg ER tablets is unsafe. This combination can dangerously lower blood sugar and raise the risk of lactic acidosis.
Truegliclaz M 60mg/500mg ...
86
MRP 99
13% off